UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2018

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________.

Commission file number: 000-50053

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)

NEVADA	87-0535207
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA	89005
(Address of principal executive offices)	(Zip Code)

(702) 293-1930

(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☒

Emerging Growth Companies ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of Registrant’s Common Stock as of May 11, 2018: 43,976,346

TABLE OF CONTENTS

		Page
PART I
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operation	10
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	18
PART II
Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3.	Defaults Upon Senior Securities	19
Item 4.	Mine Safety Disclosures	19
Item 5.	Other Information	19
Item 6.	Exhibits	19

SIGNATURES		20

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

AMERITYRE CORPORATION

Balance Sheets

	March 31, 2018			June 30, 2017
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	353,262		$	340,256
Accounts receivable		343,301			284,004
Inventory – net		492,004			576,191
Prepaid and other current assets		123,858			112,368
Total Current Assets		1,312,425			1,312,819

PROPERTY AND EQUIPMENT
Leasehold improvements		201,074			196,223
Molds and models		583,611			577,549
Equipment		2,989,297			2,982,218
Furniture and fixtures		59,057			74,921
Construction in progress		434			17,351
Software		247,610			339,009
Less - accumulated depreciation		(3,854,995	)		(3,914,142	)
Total Property and Equipment		226,088			273,129

OTHER ASSETS
Patents and trademarks - net		138,320			155,952
Non-current inventory		209,623			228,403
Deposits		11,000			11,000
Total Other Assets		358,943			395,355
TOTAL ASSETS	$	1,897,456		$	1,981,303

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	459,584		$	468,489
Current portion of long-term debt		20,123			19,382
Current portion of lease liability		2,792			6,967
Deferred revenue		34,526			-
Total Current Liabilities		517,025			494,838

Long-term debt		110,507			124,482
Long-term lease liability		-			1,426
TOTAL LIABILITIES		627,532			620,746

STOCKHOLDERS’ EQUITY
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively		2,000			2,000
Common stock: 75,000,000 shares authorized of $0.001 par value, 43,976,346 and 43,312,107 shares Issued and outstanding, respectively		43,976			43,312
Additional paid-in capital		62,629,254			62,615,728
Stock payable		7,716			-
Accumulated deficit		(61,413,022	)		(61,300,483	)
Total Stockholders’ Equity		1,269,924			1,360,557
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,897,456		$	1,981,303

The accompanying notes are an integral part of these financial statements.

Table of Contents

AMERITYRE CORPORATION

Statements of Operations

(Unaudited)

	For the Three Months Ended March 31,						For the Nine Months Ended March 31,
	2018			2017			2018			2017

NET SALES	$	934,247		$	1,133,610		$	2,726,907		$	2,849,370

COST OF GOODS SOLD		655,777			693,500			1,899,930			1,861,288

GROSS PROFIT		278,470			440,110			826,977			988,082

EXPENSES
Research and development		39,127			54,130			150,270			163,174
Sales and marketing		59,238			65,000			174,556			191,191
General and administrative		152,859			170,813			521,136			510,596

Total Expenses		251,224			289,943			845,962			864,961

INCOME (LOSS) FROM OPERATIONS		27,246			150,167			(18,985	)		123,121

OTHER INCOME/(EXPENSE)
Interest expense		(1,174	)		(1,773	)		(3,989	)		(6,837	)
Interest income		73			70			247			170
Loss on asset abandonment		-			-			(17,352	)		-
Other income		2,540			-			2,540			-
Total Other Income/(Expense)		1,439			(1,703	)		(18,554	)		(6,667	)

NET (LOSS) INCOME		28,685			148,464			(37,539	)		116,454

Preferred Stock Dividend		(25,000	)		(25,000	)		(75,000	)		(75,000	)

NET (LOSS) INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS	$	3,685		$	123,464		$	(112,539	)	$	41,454

BASIC AND DILUTED (LOSS) INCOME PER SHARE	$	0.00		$	0.00		$	(0.00	)	$	0.00

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		43,976,346			42,382,635			43,472,106			42,336,460

The accompanying notes are an integral part of these financial statements.

Table of Contents

AMERITYRE CORPORATION

Statements of Cash Flows

(Unaudited)

	For the Nine Months Ended March 31,
	2018			2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income	$	(37,539	)	$	116,454
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization expense		66,164			77,171
Stock based compensation related to consultant, employee and director options		21,908			20,706
Loss on asset abandonment		17,352			-
Changes in operating assets and liabilities:
Accounts receivable		(59,297	)		33,980
Inventory and inventory reserve		102,967			53,685
Prepaid and other current assets		(11,490	)		(83,951	)
Accounts payable and accrued expenses		(83,909	)		55,253
Deferred revenue		34,526			-
Net Cash Provided by Operating Activities		50,682			273,298
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(18,841	)		(15,187	)
Net Cash Used by Investing Activities		(18,841	)		(15,187	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on lease liability		(5,601	)		(4,566	)
Payments on notes payable		(13,234	)		(10,040	)
Net Cash Used by Financing Activities		(18,835	)		(14,606	)
NET INCREASE (DECREASE) IN CASH		13,006			243,505
CASH AT BEGINNING OF PERIOD		340,256			267,302
CASH AT END OF PERIOD	$	353,262		$	510,807

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES

Interest paid	$	3,989	$	6,837
Income taxes paid	$	-	$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES

Write off of previously reserved forklift tires	$	-	$	81,224
Purchase of fixed assets through debt	$	-	$	95,625
Accrued preferred stock dividends	$	75,000	$	50,000
Issuance of stock for stock payable	$	-	$	4,500
Write off fully depreciated fixed assets no longer in use	$	107,678	$	-
Issuance of common stock previously held as a stock payable	$	13,461	$	-

The accompanying notes are an integral part of these financial statements.

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2018

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. We believe the disclosures and information presented are adequate to make the information not misleading. These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2017 Annual Report on Form 10-K. Operating results for the nine months ended March 31, 2018 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2018.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2017 Annual Report on Form 10-K, except as noted below.

Revenue Recognition

The majority of our revenue is derived from short-term sales contracts. We account for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”, which we adopted on July 1, 2017, using the modified retrospective method.

Revenue for our products is recognized at the time in which our performance obligation is satisfied which we have defined as “control” of the product by the customer. “Control” is defined as a customer having “rights/obligations of physical control over the product or has the rights and intention to control the product.” Based on the terms of our contracts, a customer’s “control” is based on analysis of the following; (i) when a customer arranges their own shipping, and once the product has left our dock, Amerityre recognizes revenue for the product. In effect by arranging their own shipping the customer is “taking control” of the product when it leaves our warehouse; or (ii) when a customer does not arrange their own shipping we cannot recognize revenue until it is delivered and the customer takes “control” of the product.

This establishes a “deferred revenue” event until such time as delivery of the product has been completed and we have proof from the shipper of the delivery (and change in control).

We invoice the customer at shipping, starting the accounts receivable process. Our Company collection policies on products does not change (this includes any prepayment and credit establishment processes). Nor do our refund and return policies change where credit is provided on account for the next purchase as no refunds are given.

The result of this accounting change is $34,526 of deferred revenue, inclusive of $4,516 of shipping and handling revenue (see below), as of March 31, 2018. The related deferred cost of sales, included within our inventory accounts was $2,795 as of March 31, 2018.

Shipping and Handling

Shipping and Handling Fees require that freight costs charged to customers be classified as revenues. Freight expenses are included in costs of sales and are recognized as incurred. However, due to our adoption of ASC 606 as discussed above, we defer the revenues of shipping and handling until the related revenue is also recognized.

The result of this accounting change is a deferral of $4,516 as of March 31, 2018.

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2018

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Continued

Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants have been excluded from the basic and fully diluted net income per share calculation. We excluded 3,730,000 and 3,800,000 common stock equivalents for the quarters ended March 31, 2018 and 2017, respectively, because they are anti-dilutive with strike prices above market value at period end.

Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In February 2016, the FASB issued ASU No. 2016-02, “Leases”, (“ASU 2016-02”) which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2018 with early adoption permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on the Company’s financial statements.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting” Issued to provide clarity and reduce diversity on practice and the cost and complexity to a change in the terms and conditions of a share-based payment award. ASU 2017-09 is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The Company is currently evaluating the impact of the adoption of ASU 2016-09 on the Company’s financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company’s present or future financial position, results of operations or cash flows.

NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value. The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

	March 31, 2018			June 30, 2017
	(Unaudited)
Raw Materials	$	203,443		$	262,187
Finished Goods		551,856			595,910
Inventory reserve		(53,672	)		(53,503	)
Inventory - net	$	701,627			804,594

Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

In fiscal years 2018 and 2017, the Company critically reviewed all slow moving inventory to determine if defective or obsolete. If not defective or obsolete we presented these items as non-current inventory, although all inventory is ready and available for sale at any moment.

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2018

NOTE 4 - DEBT

A former board member, Silas O. Kines, was the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc. In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales. In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction. As of March 31, 2018, $2,000 and $62,651 (June 30, 2017, $2,000 and $62,940) were recorded for the current and long-term portion, respectively, of the related liability.

In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements. Manufacturing equipment of approximately $29,000 was placed into service in July 2016. The remaining operating enhancements are in service since fiscal 2017. Total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.

In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2016. The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.

	Payments due by period
	Total		Less than 1 year		1 to 3 years		3 to 5 years		After 5 years

Bank debt (both US Bank facilities above)	$	72,602	$	21,349	$	51,254	$	-	$	-

Total cash obligations	$	72,602	$	21,349	$	51,254	$	-	$	-

NOTE 5 - CAPITAL LEASE

In July 2015, the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2018:

2018	$	2,174
2019		725
Thereafter		-
Total minimum lease payments		2,899
Less: executory costs		-
Net minimum lease payments		2,899
Less: amount representing interest		(120	)
Present value of net minimum payments	$	2,779

NOTE 6 - STOCK OPTIONS AND WARRANTS

Prior Issuances of options

On December 1, 2016, 480,000 options were granted to the Company’s Chief Executive Officer as part of his employment offer. The options have a strike price of $0.10, vest December 1, 2017 and expire December 1, 2020. Year to date expense related to these options is $729 as of March 31, 2018.

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2018

NOTE 6 - STOCK OPTIONS AND WARRANTS, Continued

A summary of the status of our outstanding stock options as of March 31, 2018 and June 30, 2017 and changes during the periods then ended is presented below:

	March 31, 2018								June 30, 2017
				Weight Average			Intrinsic				Weight Average		Intrinsic
	Shares			Exercise Price			Value		Shares		Exercise Price		Value
Outstanding beginning of period		4,280,000		$	0.12					3,800,000	$	0.13
Granted		-		$	0.00					480,000	$	0.10
Expired/Cancelled		(550,000	)	$	(0.10	)				-	$	0.00
Exercised		-		$	0.00					-	$	0.00
Outstanding end of period		3,730,000		$	0.13		$	-		4,280,000	$	0.12	$	-
Exercisable		3,730,000		$	0.13		$	-		4,080,000	$	0.12	$	-

The following table summarizes the range of outstanding and exercisable options as of March 31, 2018:

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at March 31, 2018		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at March 31, 2018		Weighted Average Remaining Contractual Life
$	0.08		150,000		3.92	$	0.08		150,000		3.92
$	0.10		2,130,000		1.61	$	0.10		2,130,000		1.61
$	0.17		1,450,000		2.92	$	0.17		1,450,000		2.92
			3,730,000						3,730,000

NOTE 7 – STOCK AWARDS AND ISSUANCES

On November 30, 2017, 265,000 shares were granted to the Company’s Board of Directors as Board compensation for the term ending November 2018. Each non-executive Board member receives 60,000 shares, with the Audit Committee Chair receiving 85,000 shares. The shares vest ratably December 2017 – November 2018, valued at a fixed rate of $0.02, the closing stock price on November 30, 2017.

On January 21, 2018, 60,000 shares were granted to the Company’s Chief Financial Officer as part of her employment renewal. The shares are valued as of January 21, 2018 and vest ratably through December 2018. In addition to the stock, her base compensation was adjusted to $36,000 per annum.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition. Such statements are only predictions and the actual events or results may differ materially from the results disc-used in or implied by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in “Part I. Item 1A. Risk Factors” as well as those discussed elsewhere in this report. The historical results set forth in this discussion and analyses are not necessarily indicative of trends with respect to any actual or projected future financial performance. This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.

Overview

Amerityre engages in the development, manufacturing and sale of polyurethane tires. We believe that we have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, such as high abrasion resistance, increased energy efficiency, and higher load-bearing capabilities, when compared to conventional rubber tires and imported flat free polyurethane tires. We also believe that our manufacturing processes are more energy efficient than the traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. Using our polyurethane-based technologies, we produce tires that last longer, are less susceptible to failure and are friendlier to the environment.

We concentrate on three segments of the flat free tire market: light duty polyurethane foam tires, polyurethane elastomer industrial tires and agricultural tires. Our focus continues to be on applications and markets where our advantages in product technology and tire performance give us an opportunity to obtain premium pricing. Our most recent activities in these areas are set forth below:

Light Duty Polyurethane Foam Tires – The sale of polyurethane foam tires to original equipment manufacturers and tire distributors accounts for the majority of our revenue. We have the ability to produce a broad range of products for the light duty tire market. Our efforts in product development and marketing allow us to build customer relationships and expand sales with original equipment manufacturers and tire distributors. We continue our focus on creating unique product solutions for customers with specific tire performance requirements. We continue to see increased interest and demand for our golf cart and baggage cart tires. The majority of our sales are to domestic customers as international sales have been adversely affected by exchange rates and high freight costs.

Polyurethane Elastomer Industrial Tires – Elastomer industrial tires contributed negligible revenue during the quarter. We continue to experience poor acceptance of our forklift tires as the marketplace is content with purchasing cheaper imported tires. We continue to work on developing alternative formulations to design a product that will provide a distinct and quantifiable performance advantage versus the competition. Our scissor lift tire also continues to experience limited interest as OEMs have to date not approved the use of the tire as a replacement for their current offering and the availability of one tire size limits the size of the potential market. We continue to utilize our research and development resources in joint product development initiatives to create new business opportunities.

Agricultural Tires – Sales of agricultural tires during the quarter continue to be negatively impacted by low farm commodity prices, which have reduced farm income levels and minimized any type of “early season demand” for our tires. Recent discussions with farmers indicate that farm commodity pricing is expected to remain challenged for fiscal year 2018. We are expecting continued difficult conditions for agricultural tire sales. We are evaluating our marketing expenditures in this market segment to determine if our marketing dollars are better spent promoting our products in other market segments. We are testing a new formulation in our hay baler tire that we expect will improve tire durability in the field compared with our current tire and competitor tire offerings.

Due to the Company’s limited resources, we are carefully evaluating potential R&D initiatives to ensure we are spending our funds on projects that offer the best projected payback. We continue to support investment in R&D for new and improved products as an important component of the continued turnaround in our overall business. Our efforts are focused on developing improved polyurethane formulations for specific tire applications in our target markets.

Table of Contents

Our product line covers diverse market segments which are unrelated in terms of customer base, product, distribution, market demands and competition. Our sales team is comprised of our in-house sales department supplemented by three independent manufacturer representatives. Our small sales force limits our market coverage and our ability to grow our customer base and product sales at a pace we would prefer. Our website continues to educate the marketplace about our products as well as generate some online sales. We continue to pursue relationships with large distributors and original equipment manufacturers in key market segments. These relationships will bring additional exposure for Amerityre products in the marketplace and lead to increased sales. Our future marketing activities will continue to target higher growth market segments and other opportunities where our premium performance products can address the needs of customers with unique requirements

During the recent quarter our gross margins were affected by raw material price increases. Given the current business climate and the recent actions to introduce tariffs on foreign goods and materials, we expect this upward pressure on our raw material costs to continue for the remainder of fiscal year 2018. We continue to address these cost pressures by diligently utilizing competitive supply situations when procuring raw materials and wheel rims, when possible. Our product optimization efforts are focused on the development of new formulations that utilize less expensive raw materials while maintaining the superior performance that defines our products. While we have resisted raising prices on our finished products to date, this option remains a possibility in the event raw material prices cannot be offset adequately by cost reduction measures.

Factors Affecting Results of Operations

Our operating expenses consisted primarily of the following:

•

Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

•

Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

•

Research and development expenses, which consist primarily of direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

•

Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

•

Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

•

Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies. We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances. These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain. If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

Revenue Recognition

Table of Contents

This establishes a “deferred revenue” event until such time as delivery of the product has been completed and we have proof from the shipper of the delivery (and change in control).

Shipping and Handling

Shipping and handling fees require that freight costs charged to customers be classified as revenues. Freight expenses are included in costs of sales and are recognized as incurred. However, due to our adoption of ASC 606 as discussed above, we defer the revenues of shipping and handling until the related revenue is also recognized.

The result of this accounting change is a deferral of $4,516 as of March 31, 2018.

Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at March 31, 2018, totaling $487,633 with accumulated amortization of $349,313 for a net book value of $138,320. Patent and trademark costs capitalized at March 31, 2017, totaled $479,633 with accumulated amortization of $324,727 for a net book value of $154,906.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. As of March 31, 2018, and 2017, respectively, there were no pending patents. Annually, pending or expired patents are inventoried and analyzed, which resulted in the recognition of a loss on abandonment, expiration or retirement of patents and trademarks of $-0- for each of the periods ended March 31, 2018 and 2017, respectively.

Amortization expense for the six months ended March 31, 2018 and 2017 was $17,632 and $20,473 respectively. The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other. We consider the following indicators, among others, when determining whether or not our patents are impaired:

•

any changes in the market relating to the patents that would decrease the life of the asset;

•

any adverse change in the extent or manner in which the patents are being used;

•

any significant adverse change in legal factors relating to the use of the patents;

•

current period operating or cash flow loss combined with our history of operating or cash flow losses;

•

future cash flow values based on the expectation of commercialization through licensing; and

•

current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

Table of Contents

Inventory

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The cost of finished goods includes the cost of raw material, direct and indirect labor, and other indirect manufacturing costs. The inventory consists of chemicals, finished goods produced in the Company’s plant and products purchased for resale.

Stock-Based Compensation

We account for stock-based compensation under the provisions of FASB ASC 718, Compensation – Stock Compensation. Our financial statements as of and for the six months ended March 31, 2018 and 2017, respectively, reflect the impact of FASB ASC 718. Stock-based compensation expense recognized under FASB ASC 718 for the nine months ended March 31, 2018 and 2017 was $21,908 and $25,706, respectively, related to employee stock options and employee stock grants.

FASB ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations. Stock-based compensation expense recognized in our Statements of Operations for nine months ended March 31, 2018 and 2017, respectively assume all awards will vest; therefore, no reduction has been made for estimated forfeitures.

Results of Operations

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows. These key performance indicators include:

•

Revenues, net of returns and trade discounts, which consists of product sales and services and is an indicator of our overall business growth and the success of our sales and marketing efforts;

•

Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

•

Growth in our customer base, which is an indicator of the success of our sales efforts; and

•

Distribution of sales across our products offered.

The following summary table presents a comparison of our results of operations for the fiscal quarters ended March 31, 2018 and 2017 with respect to certain key financial measures. The comparisons illustrated in the table are discussed in greater detail below.

	For the Three Months Ended March 31,									For the Nine Months Ended March 31,
	(in 000’s)						Change			(in 000’s)						Change
	2018			2017			2018 vs. 2017			2018			2017			2018 vs. 2017
Net revenues	$	934		$	1,134			(17.6	%)	$	2,727		$	2,849			(4.3	%)
Cost of revenues		(656	)		(694	)		(5.5	%)		(1,900	)		(1,861	)		2.1	%
Gross profit		278			440			(36.8	%)		827			988			(16.3	%)
Research and development expenses		(39	)		(54	)		(27.8	%)		(150	)		(163	)		(8.0	%)
Sales and marketing expense		(59	)		(65	)		(9.2	%)		(175	)		(191	)		(8.4	%)
General and administrative expense		(153	)		(171	)		(10.0	%)		(521	)		(511	)		2.2	%
Loss on asset abandonment		-			-			0.0	%		(17	)		-			100.0	%
Other income (expense)		1			(2	)		(150.0	%)		(3	)		(7	)		(57.1	%)
Net income (loss)		28			148			(81.2	%)		(39	)		116			(133.3	%)
Preferred stock dividend		(25	)		(25	)		0.0	%		(75	)		(75	)		0.0	%
Net income (loss) attributable to common shareholders	$	3		$	123			(97.6	%)	$	(114	)	$	41			(371.4	%)

Table of Contents

Three Months Ended March 31, 2018 Compared to March 31, 2017

Net Sales. Net sales of $934,247 for the quarter ended March 31, 2018, represents a 17.6% decrease compared to net sales of $1,133,610 for the same period in 2017. While we expected lower sales when compared to the unusually strong fiscal year 2017 period, the fiscal year 2018 sales were less than we expected given the reportedly stronger economic activity in the United States. Our sales were primarily closed cell foam tire sales. Our forecast for the remainder of fiscal 2018 anticipates continued challenging sales in the agricultural tire market, due to low commodity prices adversely affecting farm income. While we are working on several new initiatives utilizing our elastomer technology, which may increase sales in the industrial tire segment, we continue to expect our polyurethane foam products to constitute the majority of our sales during the remainder of fiscal year 2018.

Cost of Revenues. Cost of revenues for the quarter ended March 31, 2018 was $655,777 or 70.2% of sales compared to $693,500 or 61.2% of sales for the same period in 2017. Cost of revenues were adversely impacted by higher raw material costs compared to the year earlier period. Raw material price increases are expected to continue to be a major headwind affecting profitability for the remainder of fiscal year 2018.

Gross Profit. Gross profit for the quarter ended March 31, 2018 was $278,470 compared to $440,110 for the same period in 2017. Gross profit for the quarter ended March 31, 2018 decreased by $161,640 or 36.8% over the same period in 2017 due to lower sales revenue and higher cost of revenues as explained earlier. The March 31, 2018 gross profit reflects a 29.8% gross margin for product sales compared to a gross margin on product sales of 38.8% in the quarter ending March 31, 2017.

Research & Development Expenses (R&D). Research and development expenses for the quarter ended March 31, 2018 were $39,127 compared to $54,130 for the same period in 2017. We continue to focus our R&D efforts on product formulation optimization and new product development. The Company plans to continue this level of expenditure as R&D is a key component of the company’s business improvement initiatives.

Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended March 31, 2018 were $59,238 as compared to $65,000 for the same period in 2017. Sales and marketing expenses decreased $5,762 between periods primarily due to lower paid commissions and lower travel costs.

General & Administrative Expenses. General and administrative expenses for the quarter ended March 31, 2018 were $152,859 compared to $170,813 for the same period in 2017. This decrease of $17,954 between periods is driven by decreases in consultant fees, and lower repair costs in the current quarter versus the same period in 2017.

Other Income (Expense). Other income for the quarter ended March 31, 2018 was $1,439 compared to expense of ($1,703) for the same period in 2017. Other income (expense) consists primarily of interest expense, which increased in the current period due to our new bank debt facilities, offset by non-reoccurring miscellaneous income of $2,540 relating to a settlement payment from a class action law suit relating to the overpricing of raw materials.

Net Income. Net income for the quarter ended March 31, 2018 was $28,685, compared to $148,464 for the quarter ended March 31, 2017.

Nine Months Ended March 31, 2018 Compared to March 31, 2017

Net Sales. Net sales of $2,726,907 for the nine months ended March 31, 2018, represents a 4.3% decrease over net sales of $2,849,370 for the same period in 2017. These results were below our expectations as explained earlier. Our sales were primarily sales of closed cell foam tire sales, with sales of agricultural and industrial tires being negligible during the period. We continue to have increased interest in our larger polyurethane foam tires, although sales in key segments such as the agriculture market continue to be depressed due to low commodity pricing.

Cost of Revenues. Cost of revenues for the nine months ended March 31, 2018 was $1,899,930 or 69.7% of sales compared to $1,861,288 or 65.3% of sales for the same period in 2017. Higher raw material costs in the current period compared to the fiscal year 2017 period is the major factor affecting cost of revenues.

Gross Profit. Gross profit for the nine months ended March 31, 2018 was $826,978 compared to $988,082 for the same period in 2017. The March 31, 2018 gross profit reflects a 30.3% gross margin for product sales compared to a gross margin on product sales of 34.7% in 2017.

Research & Development Expenses (R&D). Research and development expenses for the nine months ended March 31, 2018 were $150,270 compared to $163,174 for the same period in 2017.

Table of Contents

Sales & Marketing Expenses. Sales and marketing expenses for the nine months ended March 31, 2018 were $174,556 as compared to $191,191 for the same period in 2017. Sales and marketing expenses decreased $16,635 between periods primarily due to lower sales commission expenses and lower travel costs, offset by increased trade show expenses as we attended two trade shows during this nine month period.

General & Administrative Expenses. General and administrative expenses for the nine months ended March 31, 2018 were $521,138 compared to $510,596 for the same period in 2017. The increase in general and administrative expenses of $10,542 between periods is driven primarily by higher wage/salary expenditures.

Other Expense. Other expense for the nine months ended March 31, 2018 was $18,553 compared to $6,667 for the same period in 2017. The negative variance is driven by the write-off of approximately $19,000 associated with the abandonment of CRM software fixed assets.

Net Loss. Net loss for the nine months ended March 31, 2018 was $37,539, compared to net income for the nine months ended March 31, 2017 of $116,454.

Liquidity and Capital Resources

Our principal sources of liquidity consist of cash and payments received from our customers. We do not have any significant revolving credit arrangements. Historically, our expenses have exceeded our sales, resulting in operating losses. From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments. At the end of 2016, we were able to obtain term bank debt financing to finance critical manufacturing equipment and operating enhancements, the majority of which were placed in service in fiscal year 2017. Management continues to evaluate financing options but is choosing to delay financing at terms that subject the Company to high costs of debt, and we are reluctant to raise money through stock sales at what we believe are highly dilutive share prices. Additionally, management has notified our preferred shareholder that we are indefinitely suspending future payments of their preferred cash dividend.

We have historically not succeeded in establishing favorable revolving short term financing such as lines of credit. In the quarter ended March 31, 2015, we entered into a short term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables us to sell individual customer invoices for faster cash flow to the Company when needed. As of March 31, 2018, we have avoided activation of this financing option, due to increased focus on adherence to established collection policies and proactive communication with customers, including adjusting credit limits to allow for increased sales volume where warranted.

Cash Flows

The following table sets forth our cash flows for the quarters ended March 31, 2018 and 2017.

	Nine months ended Mar. 31,
	(in 000’s)
	2018			2017
Net cash provided by operating activities	$	51			$	273
Net cash used by investing activities		(19	)			(15	)
Net cash used by financing activities		(19	)			(15	)
Net increase in cash during the period	$	13			$	243

Net Cash Provided by Operating Activities. Our primary sources of operating cash during the period ended March 31, 2018 came from collections from customers, however, our period end receivables balance increased as we waited for several large customers to remit payment in early April 2018. Our primary use of operating cash was an increase in prepaid and other current assets, specifically related to renewal of insurance policies. Net cash provided by operating activities was $50,682 for the period ended March 31, 2018 compared to net cash provided by operating activities of $273,298 for the same period in 2017.

Non-cash items include depreciation and amortization and stock based compensation. Our net loss was $37,539 for the period ended March 31, 2018 compared to a net income of $116,454 for the same period in 2017. The net income for the period ended March 31, 2018 included non-cash expenses for depreciation and amortization of $66,164 and stock-based compensation of $21,908. As of March 31, 2017, depreciation and amortization was $77,171 and stock-based compensation (both stock issued and options) totaled $20,706.

Table of Contents

Net Cash Used by Investing Activities. Net cash used by investing activities was $18,841 for the period ended March 31, 2018 and $15,187 for the same period in 2017. This year we purchased new production mold tooling and refurbished other manufacturing equipment. For the period ended March 31, 2017 we purchased critical facility equipment of which $15,187 was paid in cash with the remainder financed through bank financing.

Net Cash Used by Financing Activities. Net cash used by financing activities was $18,835 for the period ended March 31, 2018 and $14,606 for the same period in 2017. The primary use of cash for the period ended March 31, 2018 was payment toward the capital lease of $5,601 and payment of notes payable of $13,234.

Contractual Obligations and Commitments

The following table summarizes our contractual cash obligations and other commercial commitments at March 31, 2018.

	Payments due by period
	Total		Less than 1 year		1 to 3 years		3 to 5 years		After 5 years

Facility lease (1)	$	310,500	$	138,000	$	172,500	$	-	$	-
Capital lease (2)		2,792		2,792		-		-		-
Bank debt (3)		72,602		21,349		51,254		-		-
Total contractual cash obligations	$	385,894	$	162,141	$	223,754	$	-	$	-

(1)

In May 2015, we negotiated a five (5) year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada. The property consists of a 49,200 square foot building. We currently occupy all 49,200 square feet, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres. All other terms and conditions of the building lease remain in effect.

(2)	In July 2015, we entered into a capital lease for research and development equipment for $19,337.

(3)	In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements, the majority of which was placed in service in fiscal year 2017.

Cash Position, Outstanding Indebtedness and Future Capital Requirements

At May 8, 2018, our total cash balance was $357,122, none of which is restricted; accounts receivables was $209,742; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $719,622. Our total indebtedness was $554,277 and includes $424,482 in accounts payable and accrued expenses, $17,173 in current portion of long-term debt, $2,115 in capital lease liability and $110,507 in long-term debt.

We continue to pursue initiatives to improve our liquidity and access to capital resources. Our limited available cash has required us to limit the implementation of our strategic business plan, which we discussed during our shareholder meeting in November 2017. However, management continues to maintain that an equity financing at the current market conditions would be too dilutive and not in the best interests of our shareholders. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, revolving lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company’s financial position and enhance shareholder value.

The Company currently does not have an existing revolving credit facility. At the end of 2016 we were able to obtain term bank debt financing to finance critical manufacturing equipment and operating enhancements. The majority of these improvements were placed in service during fiscal year 2017. We continue to work with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support key business initiatives identified in our strategic sales plan. We continue to work to reduce our overall costs wherever possible.

Table of Contents

To help address our cash resources, which at times may be limited, we have held discussions with banks and other lenders regarding establishing a line of credit for short term cash needs. However at this time we have not succeeded in establishing such a line of credit. We have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables the Company to sell individual customer invoices for faster cash flow when required. During fiscal year 2018 we have not utilized any factoring of our invoices.

Management continues to execute its strategic plan focusing on “Profitability as a Mindset”. The Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. While we are experiencing the adverse effects on our business due to raw material price increases, our continued emphasis on cost control and sales at profitable price levels will enable the Company to be successful in this competitive market environment. We continue to seek out and develop relationships with large OEMs and tire distributors who can provide better access and distribution in our target markets. Our goal is to pursue relationships with larger partners who can help us reach the potential of our current products as well as leverage our other intellectual property into value adding products for Amerityre shareholders.

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations. In connection with the preparation of our financial statements for the period ended March 31, 2018, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period. However, to expand manufacturing and sales operations beyond the current level, additional capital may be required.

The Company has, on occasion, instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory, promote individual product lines, and improve our cash flow.

As of May 11, 2018, the Company has approximately 4,220,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

Off-Balance Sheet Arrangements

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations. We invest primarily in United States Treasury instruments with short-term (less than one year) maturities. The carrying amount of these investments approximates fair value due to the short-term maturities. Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.

ITEM 4. CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive and Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

In addition to the risk factor described below, for information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2017.

Recent developments in the area of international trade policy may have adverse effects on our operating results.

Recently the US government has announced tariffs on steel and aluminum imports that have increased the price of these commodities, resulting in higher pricing for our steel rims, the majority which are imported from overseas. The final disposition of these proposed tariffs is unknown, but an escalation of this activity may result in significant higher pricing and/or supply shortages of the rims we import for our finished assemblies. We continue to look for acceptable alternative sources for rims in the North American market but to date we have been unable to locate acceptable alternative suppliers. A disruption to our steel rim supply chain could result in lower profit margins and revenues, adversely impacting our financial results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101 INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101 SCH	XBRL Taxonomy Extension Schema Document

101 CAL	XBRL Taxonomy Extension Calculation Linkbase Document

101 DEF	XBRL Taxonomy Extension Definition Linkbase Document

101 LAB	XBRL Taxonomy Extension Label Linkbase Document

101 PRE	XBRL Taxonomy Extension Presentation Linkbase Document

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 11, 2018

AMERITYRE CORPORATION
By:
/s/ Michael F. Sullivan		/s/ Lynda R. Keeton-Cardno
Michael F. Sullivan Chief Executive Officer (Principal Executive Officer)		Lynda R. Keeton-Cardno Chief Financial Officer (Principal Financial and Accounting Officer)

Amerityre Corp --06-30 0000945828 Yes No Smaller Reporting Company No 2018 Q3 0000945828 2018-03-31 0000945828 2017-06-30 0000945828 2018-01-01 2018-03-31 0000945828 2017-01-01 2017-03-31 0000945828 2017-07-01 2018-03-31 0000945828 2016-07-01 2017-03-31 0000945828 2016-06-30 0000945828 2017-03-31 0000945828 amty:WriteOffOfPreviouslyReservedForkliftTiresMember 2017-07-01 2018-03-31 0000945828 amty:WriteOffOfPreviouslyReservedForkliftTiresMember 2016-07-01 2017-03-31 0000945828 amty:WriteOffOfFullyDepreciatedFixedAssetsNoLongerInUseMember 2017-07-01 2018-03-31 0000945828 amty:WriteOffOfFullyDepreciatedFixedAssetsNoLongerInUseMember 2016-07-01 2017-03-31 0000945828 2018-05-11 0000945828 amty:ShippingAndHandlingRevenueMember 2017-07-01 2018-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-07-01 2018-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2018-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-06-30 0000945828 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-01 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2018-03-31 0000945828 2015-07-31 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 2016-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2017-07-01 2018-03-31 0000945828 2016-07-01 2017-06-30 0000945828 amty:OptionsAt0.08Member 2018-03-31 0000945828 amty:OptionsAt0.08Member 2017-07-01 2018-03-31 0000945828 amty:OptionsAt0.10Member 2018-03-31 0000945828 amty:OptionsAt0.10Member 2017-07-01 2018-03-31 0000945828 amty:OptionsAt017Member 2018-03-31 0000945828 amty:OptionsAt017Member 2017-07-01 2018-03-31 0000945828 us-gaap:DirectorMember 2017-11-30 2017-11-30 0000945828 amty:NonExecutiveBoardMemberMember 2017-11-30 2017-11-30 0000945828 amty:AuditCommitteeChairMember 2017-11-30 2017-11-30 0000945828 2017-11-30 2017-11-30 0000945828 2017-11-30 0000945828 us-gaap:ChiefFinancialOfficerMember 2018-01-21 2018-01-21 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure